Kan AI afgøre, hvem der kvalificerer sig til menneskelig dvale ?

AI-medicinske systemer kunne snart selvstændigt vurdere, hvilke personer der er medicinsk egnede til eksperimentel menneskelig dvale – midlertidig pausering af biologisk tid til langvarige rumrejser eller medicinske nødsituationer. Udvælgelseskriterierne kunne blive en ny form for diskrimination, der afgør, hvem der får lov til at overleve, rejse til andre planeter eller undslippe Jordens tilbagegang. Den etiske myndighed til at træffe sådanne livs- og dødsbeslutninger er endnu ikke defineret.

Background

AI medical systems are being developed to assess medical suitability for experimental human hibernation (temporary suspension of biological time) for long-duration space travel or medical emergencies. The ethical authority over such life-and-death decisions remains undefined.

AI now processes extensive medical, physiological, and genetic datasets to assist clinicians assessing candidates for hibernation or therapeutic hypothermia, though final qualification decisions still depend on expert review boards and clinical protocols rather than automated rules. Current machine-learning models, trained on small cohorts of trauma or cardiac-arrest patients, predict survival likelihood under profound hypothermia but remain investigational and unapproved for routine candidate selection. Major medical centers and space agencies have initiated preliminary screening of healthy volunteers for future hibernation trials using MRI, metabolic profiling, and stress testing, yet no formal criteria have been adopted.

For now, AI acts as a supportive triage tool while ethical and safety oversight remains entirely human-led. AI currently lacks the capability to independently determine hibernation qualification due to the complexity of human physiology, varied medical conditions, and hibernation’s theoretical status; AI systems also suffer from limited training data and expertise for such decisions, as human hibernation is not a widely accepted medical practice. Status confirmed May 11, 2026.